# Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France

> **NCT07048795** · — · RECRUITING · sponsor: **mylife Diabetes Care AG** · enrollment: 125 (estimated)

## Conditions studied

- Diabetes Type 1

## Interventions

- **OTHER:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT07048795
- **Lead sponsor:** mylife Diabetes Care AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-11
- **Primary completion:** 2027-03
- **Final completion:** 2027-12
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07048795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07048795, "Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT07048795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*